Novartis begins tender offer for MorphoSys at a premium price of 68 euros per share in cash.
Experiencing the 2024 total solar eclipse in New Brunswick | SaltWire #solareclipse #eastcoastBERLIN - Novartis said on Thursday that its tender offer for MorphoSys has begun, with an offer price of 68 euros per share in cash, corresponding to a premium of 142% on the volume-weighted average price during the last three months.The acceptance period will begin on Thursday and end at midnight on May 13, added Novartis .
Reuters reported in February that the drug maker was in advanced talks to acquire MorphoSys AG, a developer of cancer treatments that has a market value of 1.6 billion euros . Headquartered in Planegg, Germany, MorphoSys develops drugs to fight deadly forms of cancers such as myelofibrosis, which is a rare type of bone marrow cancer, and certain types of knotty lymphomas.
Novartis said that Deutsche Bank is acting as share tender agent and The Bank of New York Mellon will serve as American Depository Shares tender agent for the offer.ADVERTISEMENT
Novartis Morphosys Tender Offer Premium Price Cancer Treatments
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Experiencing the 2024 total solar eclipse in New BrunswickOleksandr Revtiukh, a Ukrainian fighter who lost his limbs in mine blasts, shares his journey of adapting to a new life.
Read more »
How to avoid a CRA audit in 2024 as complex new rules come into playNew rules for claiming employee expenses and novel reporting requirements on underused housing and trusts might trip up taxpayers and attract unwanted scrutiny from the CRA.
Read more »
How to avoid a CRA audit in 2024 as complex new rules come into playNew rules for claiming employee expenses and novel reporting requirements on underused housing and trusts might trip up taxpayers and attract unwanted scrutiny from the CRA.
Read more »
How to avoid a CRA audit in 2024 as complex new rules come into playNew rules for claiming employee expenses and novel reporting requirements on underused housing and trusts might trip up taxpayers and attract unwanted scrutiny from the CRA.
Read more »
A spring 2024 guide to vehicle buying, including the latest on new vs usedRob Carrick interviews the CEO of Clutch.ca for the latest insights for going car shopping in the current market
Read more »
New schools, no tax increases and running a deficit: Highlights from the 2024-25 Sask. budgetThe 2024-25 Saskatchewan budget was released with a focus on 'classrooms, care and communities.'
Read more »